Affiliate disclosure: This article contains affiliate links. If you buy through them, we may earn a commission at no extra cost to you. This does not influence our assessment of the evidence below.
Evidence rating: Preliminary to moderate — genistein has solid randomized data in menopausal women, turmeric has modest weight data, and the rest is unsupported
What Venus Factor Claims To Be
Venus Factor is a capsule supplement aimed at women over 35, bundled with a digital body-sculpting program. The marketing frames it around leptin — the hormone that signals satiety and fat stores to the brain — claiming the formula supports “leptin output, sensitivity, and the strength of leptin’s fat-burning signal,” alongside general hormonal and metabolic support during age-related change.
Leptin sensitivity is a genuine area of obesity research. Whether four plant extracts can move it is a different question, and none of the trials below measured leptin at all. What the research does cover is narrower and, in one case, quite good.
What’s Actually In It
Four named ingredients in a proprietary blend, with no individual doses published:
- Genistein (a soy isoflavone)
- Arctic lingonberry
- Himalayan turmeric
- Camellia sinensis (green tea extract)
Four ingredients is unusually restrained for this category. The trade-off is that when one of the four has no supporting literature, it’s a quarter of the formula rather than a rounding error.
What The Research Shows
According to PubMed, genistein is the standout here, and specifically in the population this product targets.
Genistein improves glucose handling in peri- and post-menopausal women. An overview synthesising four separate meta-analyses of randomized trials found that fasting insulin and HOMA-IR (the standard index of insulin resistance) were significantly lower in peri- and postmenopausal women taking isoflavones. Genistein specifically — as distinct from mixed soy isoflavones — showed beneficial effects on fasting insulin, blood glucose and HOMA-IR regardless of the population studied. The authors were careful to note high heterogeneity and methodological weakness in the underlying reviews, which caps how confident anyone should be. DOI
A one-year randomized trial found genistein reduced hot flashes in exactly this demographic. 120 postmenopausal women with metabolic syndrome were randomized to 54 mg of genistein daily or placebo for twelve months. The genistein group showed significant reductions in hot flash frequency, alongside falls in visfatin — an inflammatory adipokine secreted by visceral fat that correlated with both BMI and hot flash count at baseline. This is a real, long-duration, placebo-controlled result in menopausal women. DOI
Turmeric’s active compound has a small weight effect. A dose-response meta-analysis of eleven randomized trials in 876 people found curcumin supplementation reduced body weight by 1.14 kg and BMI by 0.48 kg/m² versus control. Waist circumference did not change significantly overall — though it did in the subgroup of trials using 1,000 mg/day or more for eight weeks or longer in overweight participants. DOI
A second curcumin analysis found the opposite pattern. Pooling eight randomized trials in 520 people with non-alcoholic fatty liver disease, curcumin significantly reduced BMI (-0.34 kg/m²) and waist circumference (-2.12 cm) but produced no significant change in body weight. Two meta-analyses of the same compound disagreeing on which anthropometric measure moves is a sign the underlying effect is small enough to flip with study selection. DOI
Green tea’s weight loss reputation does not survive the trials. A meta-analysis restricted to randomized, double-blind, 12-week-plus studies in overweight and obese adults found no statistically significant effect of green tea or its extracts on body weight, BMI, waist circumference or hip circumference. The one significant finding — a 0.76% reduction in fat mass — was described by the authors themselves as not clinically relevant. DOI Paired with exercise it does marginally better: ten randomized trials found small, consistent advantages the reviewers called “quite minimal additive benefit,” with no improvement in lipids. DOI
Arctic lingonberry: I found no human trials to cite. Searching PubMed for lingonberry against weight, metabolic or hormonal outcomes did not turn up randomized human evidence I could stand behind, and I won’t represent preclinical berry research as clinical support.
One practical note from the search: a crossover study in postmenopausal women found a 60 mg soy isoflavone supplement did not affect levothyroxine absorption — useful reassurance for women in this age group on thyroid replacement. DOI
The Honest Verdict
What holds up: Genistein in menopausal and perimenopausal women is a legitimately good pick — a year-long placebo-controlled trial for vasomotor symptoms and pooled meta-analytic support for insulin sensitivity. Curcumin’s weight effect is small but real and consistent in direction.
What doesn’t: The leptin framing. Nothing in the published evidence for these four ingredients establishes an effect on leptin output or sensitivity in humans — that’s the marketing story, not the research. Green tea’s contribution to weight loss is close to nil on the trial data, lingonberry has no human evidence I could find, and with no dose panel there’s no way to know whether the genistein here approaches the 54 mg used in the trial that worked.
Who this makes sense for: A woman in perimenopause or after, dealing with hot flashes and creeping insulin resistance, who is already exercising and would use the bundled program. Anyone with a history of hormone-sensitive breast cancer should raise phytoestrogens with their oncologist first.
Who should skip it: Anyone expecting fat burning independent of diet and exercise. Men, for whom the entire evidence base above is irrelevant.
Check current pricing and availability
View Venus Factor on the official site
This article is for informational purposes only and is not medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. Talk to your physician before starting any supplement, especially if you have a diagnosed condition or take medication.
Research cited via PubMed:
- Maliehe A, et al. J Menopausal Med. 2019;25(2):69-73. DOI
- Bitto A, et al. Endocrine. 2016;55(3):899-906. DOI
- Mousavi SM, et al. Crit Rev Food Sci Nutr. 2020;60(1):171-180. DOI
- Baziar N, et al. Phytother Res. 2020;34(3):464-474. DOI
- Baladia E, et al. Nutr Hosp. 2014;29(3):479-90. DOI
- Gholami F, et al. J Int Soc Sports Nutr. 2024;21(1):2411029. DOI
- Persiani S, et al. Drug Res (Stuttg). 2016;66(3):136-40. DOI